Sarah Ketterer - Causeway Capital Management
Holding/activity history for AbbVie Inc. (ABBV)
← All ABBV superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q2 | 0 | 0.00 | Sell 100.00% | 1.02 | $153.58–181.90 · VW $165.29i | SEC | |
| 2024 Q1 | 213,613 | 1.02 | Reduce 46.98% | 0.75 | $154.77–182.89 · VW $172.21i | $38,918,725 | SEC |
| 2023 Q4 | 402,866 | 1.59 | Add 1.43% | 0.02 | $135.85–155.89 · VW $144.75i | $62,432,052 | SEC |
| 2023 Q3 | 397,183 | 1.56 | Add 17.14% | 0.23 | $132.70–154.88 · VW $147.26i | $59,204,099 | SEC |
| 2023 Q2 | 339,060 | 1.20 | Buy | 1.20 | $130.96–166.20 · VW $143.24i | $45,681,571 | SEC |
Price snapshot:
Current price$248.00
52-week low$180.35
52-week high$261.64